8th AABIP Annual Conference
14-16 August 2025; Austin, Texas USA

Jointly provided by Partners for Advancing Clinical Education and the American Association for Bronchology and Interventional Pulmonology

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and the American Association for Bronchology and Interventional Pulmonology. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Centre (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Education

Partners designates this live activity for a maximum of 17.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Day	Maximum Credits
14/08/2025	4.75
15/08/2025	6.25
16/08/2025	6.0
Total Credits:	17.0

American Board of Internal Medicine Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 17.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

To receive CME credit and/or MOC points, you MUST pass the posttest and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through Partner’s Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records. By sharing your Diplomate Board ID # and DOB, you are giving Partners permission to use this information/data to report your participation to these Boards JA-PARS.

Target Audience

This activity is intended for interventional Pulmonologists, Advanced Diagnostic Bronchos­copists, Critical Care specialists, Thoracic Surgeons, Advanced Practice Providers, and Trainees who care for patients with bronchology and interventional pulmonology diseases.

Educational Objectives

Upon completion of this activity, participants should be able to:

• Address individual needs in compliance with their Continuous Professional Development (CPD) plan.
• Discuss current trends in thoracic disease management to enhance patient treatment protocols.
• Analyze controversies in chronic obstructive airway disease treatment to apply the most effective approaches.
• Describe advances in guided bronchoscopy to improve precision in clinical interventions.
• Demonstrate the application of updated anesthetic techniques in interventional pulmonology for enhanced patient safety.
• Discuss the latest therapeutic options for early endobronchial tumors in clinical practice.

Faculty and Disclosure of Conflicts of Interest

Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners’ policies. Others involved in the planning of this activity have no relevant financial relationships.

• Disclosure information will be available here at least one week prior to the event.

Disclosure of Unlabeled Use

This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Kenes Education. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Commitment to the Highest Standards in CME/CPD

Kenes Group is committed to being a valuable and knowledgeable partner in the design and delivery of educationally strong, independent, transparent, and effective CME/CPD programmes. Kenes is a proud member of the Good CME Practice Group (gCMEp), a member organisation contributing to improving health outcomes by: 

• Championing best practice in CME/CPD 
• Maintaining and improving standards  
• Mentoring and educating  
• Working in collaboration with critical stakeholders